| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 93.039.076 $ | 78,38 | 4.549.873 | |||||||
| APOGEE THERAPEUTICS INC | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 1.534.928 $ | 1,29 | 11.447 | |
| ORUKA THERAPEUTICS INC | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 1.427.190 $ | 1,20 | 14.788 | |
| DIANTHUS THERAPEUTICS INC | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 1.324.739 $ | 1,12 | 12.390 | |
| ERASCA INC | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 1.285.365 $ | 1,08 | 70.819 | |
| TWIST BIOSCIENCE CORP | Twist Bioscience Corporation | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 1.279.137 $ | 1,08 | 13.972 | |
| KYMERA THERAPEUTICS INC | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 1.251.450 $ | 1,05 | 12.103 | |
| SPYRE THERAPEUTICS INC | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 1.240.040 $ | 1,04 | 12.611 | |
| REVOLUTION MEDICINES INC | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.231.510 $ | 1,04 | 6.567 | |
| CG ONCOLOGY INC | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 1.227.387 $ | 1,03 | 17.241 | |
| PROTAGONIST THERAPEUTICS INC | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.223.201 $ | 1,03 | 8.952 | |
| PRAXIS PRECISION MEDICINES INC | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 1.211.003 $ | 1,02 | 3.934 | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.200.380 $ | 1,01 | 1.574 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 1.174.674 $ | 0,99 | 30.174 | |
| NATERA INC | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 1.170.914 $ | 0,99 | 4.373 | |
| ARROWHEAD PHARMACEUTICALS INC | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 1.133.210 $ | 0,95 | 13.387 | |
| TRAVERE THERAPEUTICS INC | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 1.132.220 $ | 0,95 | 20.258 | |
| ROIVANT SCIENCES LTD | Roivant Sciences Ltd. | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 1.130.152 $ | 0,95 | 33.328 | |
| RELAY THERAPEUTICS INC | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 1.128.934 $ | 0,95 | 59.954 | |
| MODERNA INC | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 1.128.634 $ | 0,95 | 20.588 | |
| VAXCYTE INC | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 1.127.406 $ | 0,95 | 20.847 | |
| BRIDGEBIO PHARMA INC | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 1.125.024 $ | 0,95 | 14.047 | |
| HALOZYME THERAPEUTICS INC | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 1.108.595 $ | 0,93 | 13.431 | |
| RHYTHM PHARMACEUTICALS INC | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 1.096.415 $ | 0,92 | 11.047 | |
| CYTOKINETICS INC | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 1.088.844 $ | 0,92 | 14.117 | |
| VIKING THERAPEUTICS INC | Viking Therapeutics, Inc. | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 1.083.001 $ | 0,91 | 34.121 | |
| AMGEN INC | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 1.079.989 $ | 0,91 | 2.804 | |
| INCYTE CORP | Incyte Corporation | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.073.768 $ | 0,90 | 8.984 | |
| MIRUM PHARMACEUTICALS INC | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 1.067.234 $ | 0,90 | 10.073 | |
| ALKERMES PLC | Alkermes plc | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 1.058.086 $ | 0,89 | 21.598 | |
| TG THERAPEUTICS INC | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 1.056.729 $ | 0,89 | 20.310 | |
| ABBVIE INC | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 1.056.206 $ | 0,89 | 4.209 | |
| VERTEX PHARMACEUTICALS INC | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 1.036.738 $ | 0,87 | 2.173 | |
| KRYSTAL BIOTECH INC | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 1.033.935 $ | 0,87 | 3.031 | |
| INSMED INC | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.016.073 $ | 0,86 | 10.305 | |
| SCHOLAR ROCK HOLDING CORP | Scholar Rock Holding Corporation | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 1.015.707 $ | 0,86 | 21.476 | |
| GILEAD SCIENCES INC | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.014.857 $ | 0,86 | 7.794 | |
| BIOMARIN PHARMACEUTICAL INC | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 1.011.757 $ | 0,85 | 16.857 | |
| UNIQURE NV | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 994.284 $ | 0,84 | 22.789 | |
| DYNE THERAPEUTICS INC | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 994.132 $ | 0,84 | 39.481 | |
| BIOGEN INC | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 989.381 $ | 0,83 | 4.875 | |
| NEUROCRINE BIOSCIENCES INC | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 981.785 $ | 0,83 | 5.886 | |
| ACADIA PHARMACEUTICALS INC | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 978.378 $ | 0,82 | 37.819 | |
| EXELIXIS INC | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 954.858 $ | 0,80 | 18.006 | |
| IMMUNOVANT INC | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 946.229 $ | 0,80 | 24.501 | |
| MADRIGAL PHARMACEUTICALS INC | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 938.846 $ | 0,79 | 2.009 | |
| GRAIL INC | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 929.331 $ | 0,78 | 13.555 | |
| CELCUITY INC | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 926.857 $ | 0,78 | 10.730 | |
| SUMMIT THERAPEUTICS INC | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 922.793 $ | 0,78 | 70.875 | |
| CRISPR THERAPEUTICS AG | CRISPR Therapeutics A.G. | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 919.104 $ | 0,77 | 19.152 | |
| UNITED THERAPEUTICS CORP | United Therapeutics Corporation | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 900.815 $ | 0,76 | 1.740 | |
| PTC THERAPEUTICS INC | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 877.941 $ | 0,74 | 12.909 | |
| ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 868.587 $ | 0,73 | 34.869 | |
| IMMUNITYBIO INC | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 851.975 $ | 0,72 | 118.825 | |
| SELLAS LIFE SCIENCES GROUP INC | SELLAS Life Sciences Group, Inc. | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 823.683 $ | 0,69 | 82.286 | |
| BEAM THERAPEUTICS INC | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 819.396 $ | 0,69 | 32.108 | |
| BIOCRYST PHARMACEUTICALS INC | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 816.964 $ | 0,69 | 90.976 | |
| VERA THERAPEUTICS INC | Vera Therapeutics, Inc. | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 808.952 $ | 0,68 | 25.201 | |
| IDEAYA BIOSCIENCES INC | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 781.142 $ | 0,66 | 22.004 | |
| DENALI THERAPEUTICS INC | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 760.742 $ | 0,64 | 33.047 | |
| TANGO THERAPEUTICS INC | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 747.178 $ | 0,63 | 27.490 | |
| ARCUTIS BIOTHERAPEUTICS INC | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 744.210 $ | 0,63 | 27.707 | |
| CELLDEX THERAPEUTICS INC | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 733.112 $ | 0,62 | 19.262 | |
| VIRIDIAN THERAPEUTICS INC | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 705.754 $ | 0,59 | 37.302 | |
| DISC MEDICINE INC | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 702.394 $ | 0,59 | 9.122 | |
| ARCUS BIOSCIENCES INC | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 693.530 $ | 0,58 | 24.602 | |
| MINERALYS THERAPEUTICS INC | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 684.421 $ | 0,58 | 26.819 | |
| IONIS PHARMACEUTICALS INC | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 668.558 $ | 0,56 | 12.914 | |
| ALNYLAM PHARMACEUTICALS INC | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 668.146 $ | 0,56 | 3.251 | |
| VERACYTE INC | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 659.087 $ | 0,56 | 14.229 | |
| IMMUNOME INC | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 649.297 $ | 0,55 | 28.528 | |
| SYNDAX PHARMACEUTICALS INC | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 638.975 $ | 0,54 | 33.542 | |
| RECURSION PHARMACEUTICALS INC | Recursion Pharmaceuticals, Inc. | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 631.431 $ | 0,53 | 210.477 | |
| SAREPTA THERAPEUTICS INC | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 630.287 $ | 0,53 | 42.415 | |
| ADMA BIOLOGICS INC | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 626.801 $ | 0,53 | 74.090 | |
| KODIAK SCIENCES INC | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 592.806 $ | 0,50 | 14.257 | |
| INTELLIA THERAPEUTICS INC | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 584.602 $ | 0,49 | 54.738 | |
| AGIOS PHARMACEUTICALS INC | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 572.331 $ | 0,48 | 19.065 | |
| IOVANCE BIOTHERAPEUTICS INC | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 562.446 $ | 0,47 | 138.193 | |
| NURIX THERAPEUTICS INC | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 544.251 $ | 0,46 | 23.449 | |
| PALVELLA THERAPEUTICS INC | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 541.839 $ | 0,46 | 3.897 | |
| NOVAVAX INC | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 523.724 $ | 0,44 | 71.547 | |
| VERICEL CORP | Vericel Corporation | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 523.347 $ | 0,44 | 11.387 | |
| BIOHAVEN LTD | Biohaven Ltd. | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 487.958 $ | 0,41 | 36.145 | |
| CAREDX INC | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 476.483 $ | 0,40 | 10.901 | |
| STOKE THERAPEUTICS INC | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 433.015 $ | 0,36 | 15.004 | |
| PRECIGEN INC | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 423.582 $ | 0,36 | 67.557 | |
| TYRA BIOSCIENCES INC | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 423.239 $ | 0,36 | 13.276 | |
| VIR BIOTECHNOLOGY INC | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 408.354 $ | 0,34 | 47.154 | |
| ZENAS BIOPHARMA INC | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 404.538 $ | 0,34 | 12.867 | |
| ANAPTYSBIO INC | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 400.200 $ | 0,34 | 7.500 | |
| FIRST TRACKS BIOTHERAPEUTICS INC | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 390.679 $ | 0,33 | 8.871 | |
| ABSCI CORP | Absci Corporation | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 384.947 $ | 0,32 | 49.479 | |
| HYPERLIQUID STRATEGIES INC | Hyperliquid Strategies, Inc. | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 374.774 $ | 0,32 | 60.350 | |
| CULLINAN THERAPEUTICS INC | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 374.055 $ | 0,32 | 22.670 | |
| XENCOR INC | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 373.784 $ | 0,31 | 18.495 | |
| CORVUS PHARMACEUTICALS INC | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 370.657 $ | 0,31 | 27.953 | |
| VOR BIOPHARMA INC | Vor BioPharma, Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 354.157 $ | 0,30 | 16.745 | |
| AVALO THERAPEUTICS INC | Avalo Therapeutics, Inc. | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 353.138 $ | 0,30 | 19.350 | |
| ARDELYX INC | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 350.049 $ | 0,29 | 70.717 | |
| ORIC PHARMACEUTICALS INC | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 344.642 $ | 0,29 | 31.133 | |
| MONTE ROSA THERAPEUTICS INC | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 332.944 $ | 0,28 | 20.154 | |
| MANNKIND CORP | MannKind Corporation | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 317.551 $ | 0,27 | 81.215 | |
| INHIBRX BIOSCIENCES INC | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 313.759 $ | 0,26 | 3.824 | |
| TAYSHA GENE THERAPIES INC | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 310.967 $ | 0,26 | 53.066 | |
| ANNEXON INC | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 302.832 $ | 0,26 | 59.437 | |
| OLEMA PHARMACEUTICALS INC | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 296.612 $ | 0,25 | 25.905 | |
| REPLIMUNE GROUP INC | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 293.306 $ | 0,25 | 26.188 | |
| SIONNA THERAPEUTICS INC | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 291.075 $ | 0,25 | 6.176 | |
| JADE BIOSCIENCES INC | Jade Biosciences, Inc. | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 288.804 $ | 0,24 | 14.623 | |
| BICARA THERAPEUTICS INC | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 283.331 $ | 0,24 | 10.455 | |
| JANUX THERAPEUTICS INC | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 278.946 $ | 0,24 | 18.388 | |
| GERON CORP | Geron Corporation | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 268.341 $ | 0,23 | 208.016 | |
| KURA ONCOLOGY INC | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 264.317 $ | 0,22 | 29.336 | |
| ARRIVENT BIOPHARMA INC | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 249.385 $ | 0,21 | 8.363 | |
| CYTOMX THERAPEUTICS INC | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 235.399 $ | 0,20 | 75.935 | |
| RIGEL PHARMACEUTICALS INC | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 228.222 $ | 0,19 | 6.200 | |
| IRONWOOD PHARMACEUTICALS INC | Ironwood Pharmaceuticals, Inc. | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 221.821 $ | 0,19 | 52.440 | |
| ALTIMMUNE INC | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 219.245 $ | 0,18 | 77.199 | |
| ALLOGENE THERAPEUTICS INC | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 217.665 $ | 0,18 | 115.779 | |
| SANA BIOTECHNOLOGY INC | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 211.219 $ | 0,18 | 67.482 | |
| SOLID BIOSCIENCES INC | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 198.445 $ | 0,17 | 24.621 | |
| DAMORA THERAPEUTICS INC | Damora Therapeutics, Inc. | EC | G2646Y104 | Long | Börsenkurs (Stufe 1) | 197.625 $ | 0,17 | 6.817 | |
| CANDEL THERAPEUTICS INC | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 193.173 $ | 0,16 | 19.298 | |
| VERASTEM INC | Verastem, Inc. | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 187.415 $ | 0,16 | 32.313 | |
| REGENXBIO INC | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 180.980 $ | 0,15 | 18.677 | |
| IMMIX BIOPHARMA INC | Immix Biopharma, Inc. | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 166.916 $ | 0,14 | 20.062 | |
| SAVARA INC | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 166.388 $ | 0,14 | 30.474 | |
| OCUGEN INC | Ocugen Inc | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 164.027 $ | 0,14 | 133.355 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 156.141 $ | 0,13 | 15.338 | |
| ARBUTUS BIOPHARMA CORP | Arbutus Biopharma Corporation | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 152.100 $ | 0,13 | 35.046 | |
| PRIME MEDICINE INC | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 145.507 $ | 0,12 | 49.831 | |
| CABALETTA BIO INC | Cabaletta Bio Inc | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 134.314 $ | 0,11 | 50.117 | |
| COMPASS THERAPEUTICS INC | Compass Therapeutics, Inc. | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 124.561 $ | 0,10 | 65.215 | |
| EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions, Inc. | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 117.462 $ | 0,10 | 16.269 | |
| MIMEDX GROUP INC | MiMedx Group, Inc. | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 116.437 $ | 0,10 | 28.193 | |
| PROTHENA CORP PLC | Prothena Corp plc | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 112.519 $ | 0,09 | 13.857 | |
| PERSPECTIVE THERAPEUTICS INC | Perspective Therapeutics, Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 111.988 $ | 0,09 | 38.484 | |
| ARS PHARMACEUTICALS INC | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 111.865 $ | 0,09 | 21.806 | |
| VANDA PHARMACEUTICALS INC | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 111.440 $ | 0,09 | 21.851 | |
| OVID THERAPEUTICS INC | Ovid therapeutics, Inc. | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 104.154 $ | 0,09 | 46.916 | |
| LEXEO THERAPEUTICS INC | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 95.671 $ | 0,08 | 23.165 | |
| ACHIEVE LIFE SCIENCES INC | Achieve Life Sciences Inc | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 82.625 $ | 0,07 | 12.870 | |
| MYRIAD GENETICS INC | Myriad Genetics, Inc. | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 82.231 $ | 0,07 | 28.752 | |
| CAPRICOR THERAPEUTICS INC | Capricor Therapeutics, Inc. | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 79.730 $ | 0,07 | 20.709 | |
| SAGIMET BIOSCIENCES INC | Sagimet Biosciences, Inc. | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 66.642 $ | 0,06 | 9.373 | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BridgeBio Oncology Therapeutics, Inc. | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 62.730 $ | 0,05 | 7.754 | |
| MAPLIGHT THERAPEUTICS INC | MapLight Therapeutics, Inc. | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 61.871 $ | 0,05 | 4.752 | |
| 93.039.076 $ | 78,38 | 4.549.873 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.